C.M. Bidwell & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,455
Closed -$34.8K 519
2023
Q2
$34.8K Sell
1,455
-150
-9% -$3.59K 0.03% 323
2023
Q1
$30.2K Buy
+1,605
New +$30.2K 0.02% 336
2020
Q1
Sell
-875
Closed -$37K 344
2019
Q4
$37K Buy
+875
New +$37K 0.03% 263